Explore our latest news
View our latest press releases including updates from our parent organisation Cancer Research UK and partner organisations.
Portfolio company Myricx Bio is set to be acquired by Novartis in a deal worth up to $1.5bn
Latest news
From early funding by Cancer Research UK, to groundbreaking research by Ed Tate, to one of Europe's largest Series A raises of 2024, including investment from us, Myricx Bio has transformed an unconventional idea into pioneering science, developing a first-in-class ADC payload platform designed to overcome key limitations of existing ADCs, with potential across multiple solid tumour types.
On the Horizon: A look at in-vivo CAR-T therapy
Expert overview
While questions remain over efficacy and delivery, in-vivo CAR-T presents a hugely exciting opportunity. Large-scale investment, promising initial results and a raft of benefits over current CAR-T approaches all add up to a real buzz in the field. So, is this a genuine breakthrough or a false dawn?
Innovation Summit 2026
Featured event
Our Innovation Summit will take place at The Science and Industry Museum, Manchester, on 3 November.
The Summit is your chance to dive deep into the world of oncology innovation and entrepreneurship. This one-day event equips researchers with the skills and mindset needed to bring their innovations to life.
Our events
We hold a range of events aimed at researchers, partners and investors including our Innovation Summit and Innovation & Entrepreneurial Awards. Through Cancer Research UK, our network has access to a number of scientific conferences each year and we also partner with a number of organisations to deliver networking and other events.
Interested in progressing world-leading cancer research?
We want to hear from researchers, entrepreneurs, partners and investors.